Background—About one half of patients with heart failure (HF) have preserved ejection
fraction (HFPEF) rather than reduced ejection fraction (HFREF). The differences in risk …

Aims Heart failure (HF) is a major public health burden worldwide. Of patients presenting
with HF, 30–55% have a preserved ejection fraction (HFPEF) rather than a reduced ejection …

Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF)
patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF) …

Background—The contributions of risk factors and disease pathogenesis to heart failure with
preserved ejection fraction (HFPEF) versus heart failure with reduced ejection fraction …

Background—Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥ 50%) or
reduced (HFrEF, EF< 50%) ejection fraction (EF), but changes in EF after HF diagnosis are …

Aims While heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF) are
well described, determinants and outcomes of heart failure with mid‐range ejection fraction …

Background—The pathogenic role of ischemic heart disease (IHD) in heart failure (HF) with
reduced ejection fraction (HFrEF; EF< 40%) is well established, but its pathogenic and …

Objectives: This study aimed to determine temporal trends in the incidence of and mortality
associated with heart failure (HF) and its subtypes (heart failure with reduced ejection …

Aims Whether prevalence and mortality of patients with heart failure with preserved or mid-
range (40–49%) ejection fraction (HFpEF and HFmREF) are similar to those of heart failure …

Background A subset of patients with heart failure (HF) and preserved left ventricular
ejection fraction (EF) previously had EF< 40%. We postulated that such “recovered” EF …